| Capecitabine |
EU/1/12/763/018 blister (PVC/PVdC/alu) |
Ecansya, Film coated tablet, 500, mg, Pack: 120 |
KRKA, d.d., Словения |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Limited, Малта; KRKA, d.d., Словения |
246.34 |
49.27 |
295.61 |
4% |
9.85 |
256.19 |
51.24 |
307.43 |
16% |
25 |
281.19 |
56.24 |
337.43 |
|
НСР-4881/17.10.2014 |
03.11.2014 |
03.11.2014 |
Неактивен |
3267 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 25 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
44.12 |
8.82 |
52.94 |
4% |
1.76 |
45.88 |
9.18 |
55.06 |
16% |
7.06 |
52.94 |
10.59 |
63.53 |
|
НСР-6165/08.05.2015; НСР-9127/27.04.2016 |
02.06.2016 |
02.06.2016 |
Заличен |
3923 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 25 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
44.12 |
8.82 |
52.94 |
4% |
1.76 |
45.88 |
9.18 |
55.06 |
16% |
7.06 |
52.94 |
10.59 |
63.53 |
|
НСР-6165/08.05.2015 |
25.05.2015 |
25.05.2015 |
Неактивен |
3923 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 50 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
106.59 |
21.32 |
127.91 |
4% |
4.26 |
110.85 |
22.17 |
133.02 |
16% |
17.05 |
127.9 |
25.58 |
153.48 |
|
НСР-2550/24.01.2014; НСР-9148/27.04.2016 |
02.06.2016 |
02.06.2016 |
Заличен |
2456 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 50 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
106.59 |
21.32 |
127.91 |
4% |
4.26 |
110.85 |
22.17 |
133.02 |
16% |
17.05 |
127.9 |
25.58 |
153.48 |
|
НСР-2550/24.01.2014 |
12.02.2014 |
12.02.2014 |
Неактивен |
2456 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 5 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
8.27 |
1.65 |
9.92 |
7% |
0.58 |
8.85 |
1.77 |
10.62 |
20% |
1.65 |
10.5 |
2.1 |
12.6 |
|
НСР-5456/16.01.2015; НСР-9149/27.04.2016 |
02.06.2016 |
02.06.2016 |
Заличен |
3517 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 5 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
8.27 |
1.65 |
9.92 |
7% |
0.58 |
8.85 |
1.77 |
10.62 |
20% |
1.65 |
10.5 |
2.1 |
12.6 |
|
НСР-5456/16.01.2015 |
02.02.2015 |
02.02.2015 |
Неактивен |
3517 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 25 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
54.22 |
10.84 |
65.06 |
4% |
2.17 |
56.39 |
11.28 |
67.67 |
16% |
8.68 |
65.07 |
13.01 |
78.08 |
|
НСР-2549/24.01.2014 |
12.02.2014 |
12.02.2014 |
Неактивен |
3923 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 5 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
8.92 |
1.78 |
10.7 |
7% |
0.62 |
9.54 |
1.91 |
11.45 |
20% |
1.78 |
11.32 |
2.26 |
13.58 |
|
НСР-1685/11.11.2013 |
28.11.2013 |
28.11.2013 |
Неактивен |
3517 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 5 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
16.1 |
3.22 |
19.32 |
6% |
0.97 |
17.07 |
3.41 |
20.48 |
18% |
2.9 |
19.97 |
3.99 |
23.96 |
|
КЦРР-2062/24.01.2013 г |
14.02.2013 |
14.02.2013 |
Неактивен |
3517 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 50 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
193.28 |
38.66 |
231.94 |
4% |
7.73 |
201.01 |
40.2 |
241.21 |
16% |
25 |
226.01 |
45.2 |
271.21 |
|
КЦ-2955/12.10.2011 |
26.10.2011 |
26.10.2011 |
Неактивен |
2456 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 25 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
82.83 |
16.57 |
99.4 |
4% |
3.31 |
86.14 |
17.23 |
103.37 |
16% |
13.25 |
99.39 |
19.88 |
119.27 |
|
КЦ-2955/12.10.2011 |
26.10.2011 |
26.10.2011 |
Неактивен |
3923 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 5 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
16.11 |
3.22 |
19.33 |
6% |
0.97 |
17.08 |
3.42 |
20.5 |
18% |
2.9 |
19.98 |
4 |
23.98 |
|
КЦ-2955/12.10.2011 |
26.10.2011 |
26.10.2011 |
Неактивен |
3517 |
| Beclometasone |
№ 6763/26.01.2010 |
Ecobec 100 MCG Easi-Breathe, Pressurised inhalation, solution, 100 mcg/dose - 200 doses, mcg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o. Chech Republic |
20.89 |
4.18 |
25.07 |
6% |
1.25 |
22.14 |
4.43 |
26.57 |
18% |
3.76 |
25.9 |
5.18 |
31.08 |
Цената е заличена с решение НСР-5554/29.01.2015 ( в сила от 16.02.2015 ) |
НСР-4307/05.08.2014 |
20.08.2014 |
20.08.2014 |
Заличен |
3123 |
| Beclometasone |
№ 6763/26.01.2010 |
Ecobec 100 MCG Easi-Breathe, Pressurised inhalation, solution, 100 mcg/dose - 200 doses, mcg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o. Chech Republic |
21.1 |
4.22 |
25.32 |
6% |
1.27 |
22.37 |
4.47 |
26.84 |
18% |
3.8 |
26.17 |
5.23 |
31.4 |
|
НСР-1804/25.11.2013 |
11.12.2013 |
11.12.2013 |
Неактивен |
3123 |
| Beclometasone |
№ 6763/26.01.2010 |
Ecobec 100 MCG Easi-Breathe, Pressurised inhalation, solution, 100 mcg/dose - 200 doses, mcg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o. Chech Republic |
21.67 |
4.33 |
26 |
6% |
1.3 |
22.97 |
4.59 |
27.56 |
18% |
3.9 |
26.87 |
5.37 |
32.24 |
КЦ-2303/10.06.2011 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
3123 |
| Beclometasone |
20030347 |
Ecobec 250 MCG Easi-Breathe, Pressurised inhalation, solution, 250 mcg/dose - 200 doses, mcg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o. Chech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland), Waterford, Ирландия |
29.32 |
5.86 |
35.18 |
6% |
1.76 |
31.08 |
6.22 |
37.3 |
18% |
5.28 |
36.36 |
7.27 |
43.63 |
промяна в обстоятелства НСР-5346/18.12.2014; промяна в обстоятелства НСР-5711/18.02.2015; Цената е заличена с решение НСР-7130/24.09.2015 ( в сила от 16.10.2015 ) |
НСР-5072/21.11.2014 |
08.12.2014 |
08.12.2014 |
Заличен |
3354 |
| Beclometasone |
№ 6764/26.01.2010 |
Ecobec 250 MCG Easi-Breathe, Pressurised inhalation, solution, 250 mcg/dose - 200 doses, mcg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o. Chech Republic |
29.75 |
5.95 |
35.7 |
6% |
1.79 |
31.54 |
6.31 |
37.85 |
18% |
5.36 |
36.9 |
7.38 |
44.28 |
КЦ-2303/10.06.2011 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
3354 |
| Salbutamol |
20010556 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
5.07 |
1.01 |
6.08 |
7% |
0.35 |
5.42 |
1.08 |
6.5 |
20% |
1.01 |
6.43 |
1.29 |
7.72 |
Протокол 191/29.09.2016 |
НСР-5962/01.04.2015.; НСР-12237/03.04.2017 |
16.04.2015 |
02.05.2017 |
Заличен |
3785 |
| Salbutamol |
20010556 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
5.07 |
1.01 |
6.08 |
7% |
0.35 |
5.42 |
1.08 |
6.5 |
20% |
1.01 |
6.43 |
1.29 |
7.72 |
Протокол 191/29.09.2016 |
НСР-5962/01.04.2015. |
16.04.2015 |
02.11.2016 |
Неактивен |
3785 |
| Salbutamol |
20010556 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Czech Republiс; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
5.07 |
1.01 |
6.08 |
7% |
0.35 |
5.42 |
1.08 |
6.5 |
20% |
1.01 |
6.43 |
1.29 |
7.72 |
|
НСР-5962/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3785 |
| Salbutamol |
20010556 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Czech Republi; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
5.1 |
1.02 |
6.12 |
7% |
0.36 |
5.46 |
1.09 |
6.55 |
20% |
1.02 |
6.48 |
1.3 |
7.78 |
|
НСР-2631/03.02.2014 |
20.02.2014 |
20.02.2014 |
Неактивен |
3785 |
| Salbutamol |
№ 121/ 09.12.2010; КЦРР-1199/13.08.2012 г. |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Czech Republi; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
5.42 |
1.08 |
6.5 |
7% |
0.38 |
5.8 |
1.16 |
6.96 |
20% |
1.08 |
6.88 |
1.38 |
8.26 |
|
НСР-70/07.06.2013 |
26.06.2013 |
26.06.2013 |
Неактивен |
3785 |
| Salbutamol |
6618/11.01.2010 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
6.83 |
1.37 |
8.2 |
7% |
0.48 |
7.31 |
1.46 |
8.77 |
20% |
1.37 |
8.68 |
1.74 |
10.42 |
|
КЦРР-1199/13.08.2012 |
28.08.2012 |
28.08.2012 |
Неактивен |
3785 |
| Salbutamol |
6618/11.01.2010 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
11.58 |
2.32 |
13.9 |
8% |
0.93 |
12.51 |
2.5 |
15.01 |
20% |
2.32 |
14.83 |
2.97 |
17.8 |
КЦ-1660/25.06.2010 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
3785 |